Total Payments
$523.12
2024 Payments
$511.43
Companies
17
Transactions
35
Medicare Patients
1,765
Medicare Billing
$87,281
Payment Breakdown by Category
Food & Beverage$523.12 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $523.12 | 35 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $133.67 | 11 | $0 (2024) |
| Lilly USA, LLC | $72.03 | 5 | $0 (2024) |
| ABBVIE INC. | $48.63 | 3 | $0 (2024) |
| Novo Nordisk Inc | $31.23 | 2 | $0 (2024) |
| W. L. Gore & Associates, Inc. | $28.42 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $28.36 | 2 | $0 (2024) |
| Merck Sharp & Dohme LLC | $25.27 | 1 | $0 (2024) |
| Dexcom, Inc. | $23.49 | 1 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $19.34 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $16.24 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $511.43 | 34 | PFIZER INC. ($133.67) |
| 2021 | $11.69 | 1 | Lilly USA, LLC ($11.69) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Obesity | ||||||
| 12/05/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: DIABETES | ||||||
| 12/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: VACCINES | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: DERMATOLOGY | ||||||
| 11/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Inflammation | ||||||
| 11/01/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/08/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/02/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: VACCINES | ||||||
| 08/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/16/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $1.45 | General |
| Category: VACCINES | ||||||
| 07/15/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: VACCINES | ||||||
| 07/09/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Diabetes | ||||||
| 07/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 06/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.12 | General |
| 05/31/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 391 | 485 | $67,297 | $20,785 |
| 2022 | 15 | 584 | 647 | $82,608 | $27,064 |
| 2021 | 12 | 391 | 442 | $57,819 | $19,845 |
| 2020 | 9 | 399 | 521 | $59,061 | $19,588 |
Total Patients
1,765
Total Services
2,095
Medicare Billing
$87,281
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 136 | 191 | $52,334 | $15,705 | 30.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 16 | 16 | $3,776 | $1,934 | 51.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 15 | $2,836 | $894.78 | 31.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 52 | 66 | $990.00 | $546.00 | 55.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 41 | 48 | $1,920 | $476.92 | 24.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 44 | 51 | $1,632 | $373.50 | 22.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 20 | 22 | $1,210 | $263.44 | 21.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 12 | 12 | $828.00 | $197.52 | 23.9% |
| 87088 | Bacterial urine culture | Office | 2023 | 13 | 15 | $510.00 | $118.95 | 23.3% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 13 | 15 | $495.00 | $118.65 | 24.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 11 | 12 | $480.00 | $88.00 | 18.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 19 | 22 | $286.00 | $68.42 | 23.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 179 | 210 | $57,540 | $19,493 | 33.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 54 | $10,168 | $3,642 | 35.8% |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | Office | 2022 | 13 | 14 | $2,800 | $960.75 | 34.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 64 | 69 | $2,760 | $697.23 | 25.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 64 | 69 | $2,208 | $512.99 | 23.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 25 | 25 | $1,725 | $414.39 | 24.0% |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | Office | 2022 | 13 | 13 | $650.00 | $295.50 | 45.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 21 | 21 | $1,155 | $277.04 | 24.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 71 | 88 | $1,320 | $260.16 | 19.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 12 | 12 | $480.00 | $114.79 | 23.9% |
| 87088 | Bacterial urine culture | Office | 2022 | 15 | 15 | $510.00 | $111.90 | 21.9% |
| 87086 | Bacterial colony count, urine | Office | 2022 | 13 | 13 | $429.00 | $95.48 | 22.3% |
| 83690 | Lipase (fat enzyme) level | Office | 2022 | 12 | 12 | $348.00 | $74.81 | 21.5% |
About Alexander Welch, NP
Alexander Welch, NP is a Primary Care healthcare provider based in Denville, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2011. The National Provider Identifier (NPI) number assigned to this provider is 1922383827.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alexander Welch, NP has received a total of $523.12 in payments from pharmaceutical and medical device companies, with $511.43 received in 2024. These payments were reported across 35 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($523.12).
As a Medicare-enrolled provider, Welch has provided services to 1,765 Medicare beneficiaries, totaling 2,095 services with total Medicare billing of $87,281. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Primary Care
- Location Denville, NJ
- Active Since 10/12/2011
- Last Updated 04/10/2024
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1922383827
Products in Payments
- PREVNAR 20 (Biological) $92.31
- JARDIANCE (Drug) $58.43
- ELIQUIS (Drug) $41.36
- VRAYLAR (Drug) $33.83
- GORE SEAMGUARD Bioabsorbable Staple Line Reinforce (Device) $28.42
- LAGEVRIO (Drug) $25.27
- Dexcom G6 Transmitter (Medical Supply) $23.49
- INGREZZA (Drug) $19.34
- TRELEGY ELLIPTA (Drug) $16.24
- QUVIVIQ (Drug) $15.11
- BREZTRI (Drug) $15.00
- MOUNJARO (Drug) $14.98
- QULIPTA (Drug) $14.80
- Kerendia (Drug) $14.11
- Wegovy (Drug) $14.11
- VOQUEZNA (Drug) $13.95
- Otezla (Drug) $13.52
- SPRAVATO (Drug) $13.46
- FARXIGA (Drug) $13.36
- ZORYVE (Drug) $13.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.